category_outlined / Notizie e Politica
Newsweek EuropeNewsweek Europe

Newsweek Europe


This exciting weekly publication offers a clear combination of news, culture and thought-provoking ideas that challenge the smart and inquisitive. Our promise is to put the reporting back into the news.

United Kingdom
Newsweek UK Ltd
Leggi di piùkeyboard_arrow_down
4,80 €(Incl. tax)
38,76 €(Incl. tax)
51 Numeri


access_time2 minuti
newsweek europe

GLOBAL EDITOR-IN-CHIEF _ Nancy Cooper CREATIVE DIRECTOR _ Michael Goesele EDITORIAL DIRECTOR _ Hank Gilman DEPUTY EDITOR (EUROPE + OPINION) _ Laura Davis MANAGING EDITOR _ Melissa Jewsbury SPECIAL PROJECTS EDITOR _ Fred Guterl EDITOR AT LARGE _ Diane Harris EDITORIAL New York Bureau Chief _ Jason Le Miere London Bureau Chief _ Robert Galster Managing Editor, Trending News _ Maria Vultaggio Managing Editor, Newsweek NEXT _ Juliana Pignataro Senior Editors _ Mo Mozuch, Peter Carbonara, Meredith Wolf Schizer, Karin Roberts Deputy Editors _ Jen Glennon (Trending), Tara Chan (Politics) Associate Editors _ James Etherington-Smith, Hannah Osborne (Science), Dom Passantino, Harriet Sinclair (Politics) London Sub-Editor _ Hannah Partos Copy Chief _ Elizabeth Rhodes Ernst Contributing Editor, Opinion _ Lee Habeeb Editorial Assistant _ Jason Pollack CREATIVE Director of Photography _ Diane Rice Contributing Art Director _ Michael Bessire Associate Art Director _ Paul Naughton Assistant Photo Editor _ Alessandra Amodio Digital Imaging Specialist _…

access_time9 minuti
brand x

A NEW YORK TIMES BESTSELLER PUBLISHED IN MAY, KATHERINE EBAN’S EXPOSE SHINES NEW LIGHT ON THE mysterious generic drug manufacturing business. Almost 90 percent of America’s prescription drugs are generics, with the majority of them made overseas. Fraud is widespread, Eban writes, in order to circumvent inspections and maximize profits. FDA oversight has been, to be kind, uneven, she says. Over the past year alone, for example, there have been recalls of dozens of batches of blood pressure medication, including two last month. A number of problems—impure ingredients, infestations of birds and flies, faked sterility testing—can be traced to India, which manufactures 40 percent of generic drugs dispensed in the U.S. The following excerpt describes the successful FDA inspection pilot program that was instituted in India in 2014, and was…

access_time3 minuti
q&a: katherine eban

How did you come up with the idea for your book? In 2008, Joe Graedon of the NPR program, The People’s Pharmacy, contacted me. Patients had been writing in with serious complaints about generic drugs that either didn’t work or caused devastating side effects. Top officials at the FDA had insisted to him that the patients’ reactions were psychosomatic. But Graedon felt something significant was wrong and urged me to look into the claims. My effort to answer a single question, what is wrong with the drugs, launched me into a decade-long reporting odyssey on four continents. Ultimately, I uncovered how generic-drug companies circumvented regulations and resorted to fraud. What obstacles did you face and how did you overcome them? As a journalist, exposing corruption in your own backyard is hard enough. But…

access_time1 minuti
talking points

“The liberal idea has become obsolete. It has come into conflict with the interests of the overwhelming majority of the population.” —RUSSIAN PRESIDENT VLADIMIR PUTIN “IF A FEMALE DALAI LAMA COMES, SHE SHOULD BE MORE ATTRACTIVE.” —THE DALAI LAMA “We obviously forbid any discussion or topics that would run counter to the major decisions made by the leaders.” —WANG GANG, VICE HEAD OF ACADEMIC AFFAIRS OF CHINA’S CENTRAL PARTY SCHOOL “I stand by the comments that I made about not wanting to go to the White House, with exception of the expletive. My mom would be very upset about that.” —MEGAN RAPINOE, U.S. WOMEN'S SOCCER TEAM CAPTAIN “I AIN’T GOING TO JAIL. ” —Cardi B “And that little girl was me.” —SEN. KAMALA HARRIS, AT THE FIRST DEMOCRATIC PRESIDENTIAL DEBATE, RECALLING BEING BUSED TO SCHOOL "MAYBE IT'S US WHO ARE…

access_time2 minuti
be safe, feel safe: safety is the key for a sustainable world

Safety should never be traded off for higher productivity. A win-win approach is necessary. To achieve these apparently conflicting goals, we take a comprehensive, interactive approach that focuses on human, technology, management, and international standards. First, an adequate level of safety knowledge is required for workers. IDEC is the market leader in Japan in terms of industrial risk assessment capabilities accounting for 40 percent of safety lead assessors and over 30 percent of robot safety assessors certified in Japan. To help the working community acquire safety knowledge, we offer seminars and consultations on safety in manufacturing and in explosion-proof work environments. In Japan alone, IDEC has held 1,600 seminars with 37,700 participants cumulatively. Secondly, IDEC offers the leading safety technology in our products. Training people alone is not enough to ensure the…

access_time8 minuti
japanese robotics to help companies drive efficiency

Industrial robots have been used on assembly lines for decades now. But recent technological advances have enabled them to take on more complex work with more speed, accuracy and efficiency than human workers, thus prompting booming global demand that shows no signs of slowing down. Global sales of industrial robots have grown sixfold in less than a decade, rising from 60,000 units in 2009 to 381,000 units in 2017, according to a report by the International Federation of Robotics (IFR), which predicts that figure to reach 630,000 units in 2021. Five major markets represented 73 percent of the total sales volume in 2017: China, Japan, South Korea, the United States and Germany. As automation continues to rise, Boston Consulting Group forecasts that 45 percent of tasks in China, Japan, and the U.S.…